Publications by authors named "Jasgit C Sachdev"

Claim this Profile
P
Pretherapy Ferumoxytol-enhanced MRI to Predict Response to Liposomal Irinotecan in Metastatic Breast Cancer.
Harshan Ravi, Andres M Arias-Lorza, James R Costello, Hyo Sook Han, Daniel K Jeong, Jasgit C Sachdev

Radiol Imaging Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors.
Pamela N Munster, Andrew E Greenstein, Gini F Fleming, Erkut Borazanci, Manish R Sharma, Jasgit C Sachdev

Clin Cancer Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial.
Amita Patnaik, Glen J Weiss, Drew W Rasco, Lisa Blaydorn, Amy Mirabella, Jasgit C Sachdev

Cancer Chemother Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors.
Michael L Maitland, Jasgit C Sachdev, Manish R Sharma, Victor Moreno, Valentina Boni

Clin Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase.
Jasgit C Sachdev, Pamela Munster, Donald W Northfelt, Hyo Sook Han, Cynthia Ma

Breast Cancer Res Treat· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial.
Kevin Kalinsky, Fangxin Hong, Carolyn K McCourt, Jasgit C Sachdev, Edith P Mitchell

JAMA Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with -Mutant Cancers.
Komal Jhaveri, Matthew T Chang, Dejan Juric, Cristina Saura, Valentina Gambardella, Jasgit C Sachdev

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy.
Arkadiusz Z Dudek, Li C Liu, James H Fischer, Elizabeth L Wiley, Jasgit C Sachdev

Breast Cancer Res Treat· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.
Devalingam Mahalingam, Manish R Patel, Jasgit C Sachdev, Lowell L Hart, Niels Halama

Br J Clin Pharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors.
Sarina A Piha-Paul, Jasgit C Sachdev, Minal Barve, Patricia LoRusso, Russell Szmulewitz

Clin Cancer Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma.
Panagiotis A Konstantinopoulos, Steven Waggoner, Gregory A Vidal, Monica Mita, John W Moroney, Jasgit C Sachdev

JAMA Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on Precision Medicine in Breast Cancer.
Jasgit C Sachdev, Ana C Sandoval, Mohammad Jahanzeb

Cancer Treat Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study.
Ramesh K Ramanathan, Ronald L Korn, Natarajan Raghunand, Jasgit C Sachdev, Ronald G Newbold

Clin Cancer Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors.
Daniel D Von Hoff, Monica M Mita, Ramesh K Ramanathan, Glen J Weiss, Alain C Mita, Jasgit C Sachdev

Clin Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Cytotoxic Chemotherapy in Metastatic Breast Cancer: Putting Taxanes in Perspective.
Jasgit C Sachdev, Mohammad Jahanzeb

Clin Breast Cancer· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors.
Amita Patnaik, Glen J Weiss, John E Leonard, Drew Warren Rasco, Jasgit C Sachdev

Clin Cancer Res· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dantrolene sodium for the treatment of aldesleukin-induced rigors in a melanoma patient.
Laleh M Azari, Vivien S Sheehan, Jasgit C Sachdev, Terreia S Jones

Ann Pharmacother· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of the HER family of receptors in the treatment of HER2-positive metastatic breast cancer.
Jasgit C Sachdev, Mohammad Jahanzeb

Clin Breast Cancer· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does race affect outcomes in triple negative breast cancer?
Jasgit C Sachdev, Saira Ahmed, Muhammad M Mirza, Aamer Farooq, Lori Kronish

Breast Cancer (Auckl)· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pattern of use of adjuvant chemotherapy for stage II colon cancer: a single-institution experience.
Raymond U Osarogiagbon, Jasgit C Sachdev, Amna G Khattak, Lori E Kronish

Clin Colorectal Cancer· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pattern of Use of Adjuvant Chemotherapy for Stage II Colon Cancer: A Single-Institution Experience.
Raymond U Osarogiagbon, Jasgit C Sachdev, Amna G Khattak, Lori E Kronish

Clin Colorectal Cancer· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of bevacizumab-based therapy in the management of breast cancer.
Jasgit C Sachdev, Mohammad Jahanzeb

Clin Breast Cancer· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis